Lifeward (LFWD) Expected to Announce Earnings on Friday

Lifeward (NASDAQ:LFWD) is expected to post its Q1 2026 results before the market opens on Friday, May 15th. Analysts expect Lifeward to post earnings of ($1.18) per share and revenue of $5.7750 million for the quarter. Individuals can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Friday, May 15, 2026 at 8:30 AM ET.

Lifeward (NASDAQ:LFWD) last announced its quarterly earnings data on Thursday, March 19th. The company reported ($3.60) EPS for the quarter, missing analysts’ consensus estimates of ($0.07) by ($3.53). The firm had revenue of $5.08 million during the quarter, compared to analyst estimates of $7.87 million. Lifeward had a negative net margin of 90.38% and a negative return on equity of 145.55%. On average, analysts expect Lifeward to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Lifeward Stock Up 1.3%

Shares of NASDAQ:LFWD opened at $6.48 on Wednesday. The company has a market cap of $9.91 million, a P/E ratio of -0.35 and a beta of 0.32. Lifeward has a 52 week low of $4.14 and a 52 week high of $17.76. The company has a 50-day moving average price of $6.75 and a 200 day moving average price of $7.08.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Citadel Advisors LLC increased its holdings in Lifeward by 1,271.8% in the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after buying an additional 198,406 shares in the last quarter. Jane Street Group LLC increased its holdings in Lifeward by 77.3% in the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock valued at $40,000 after buying an additional 29,927 shares in the last quarter. Virtu Financial LLC increased its holdings in Lifeward by 158.0% in the fourth quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock valued at $35,000 after buying an additional 37,037 shares in the last quarter. Finally, HRT Financial LP increased its holdings in Lifeward by 149.7% in the fourth quarter. HRT Financial LP now owns 49,081 shares of the company’s stock valued at $28,000 after buying an additional 29,423 shares in the last quarter. 26.76% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of Lifeward in a research report on Tuesday, April 21st. HC Wainwright increased their target price on shares of Lifeward to $10.00 and gave the company a “buy” rating in a report on Thursday, March 19th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $10.00.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.